What are the recommended acute and preventive treatments for migraine in pregnancy?

Migraine Management in Pregnancy

For acute migraine treatment in pregnancy, use acetaminophen as first-line therapy; if inadequate, add a triptan (particularly sumatriptan) as second-line, avoiding NSAIDs after 20 weeks gestation and avoiding ergots, gepants, and ditans entirely. For prevention, use propranolol or low-dose amitriptyline only when migraine is severely disabling despite adequate acute treatment.

Acute Treatment Algorithm

First-Line: Acetaminophen

• Start with acetaminophen at adequate doses (up to 1000 mg per dose, not exceeding 3000-4000 mg daily) 1, 2, 3
• This is the safest option throughout all trimesters
• Ensure patients are using therapeutic doses before escalating therapy

Second-Line: Triptans (If Acetaminophen Fails)

• Sumatriptan has the most safety data in pregnancy and should be the preferred triptan 4, 2, 3
• Use sporadically, not chronically 3
• Available evidence supports triptans over butalbital combinations 2
• Other triptans may be considered but have less pregnancy-specific data

Third-Line: NSAIDs (Timing-Dependent)

• Can use ibuprofen or naproxen ONLY between 12-20 weeks gestation 3
• Absolutely contraindicated after 20 weeks due to risks of premature ductus arteriosus closure, oligohydramnios, and pulmonary hypertension
• Avoid in first trimester due to potential miscarriage risk
• This creates a narrow therapeutic window

Adjunctive Treatment for Severe Nausea/Vomiting

• Metoclopramide or prochlorperazine can be added as antiemetics 2
• Particularly useful when oral medications cannot be tolerated

Medications to AVOID in Pregnancy

• Ergots (ergotamine, dihydroergotamine): Contraindicated - uterotonic effects, risk of miscarriage 5
• Gepants (rimegepant, ubrogepant, zavegepant): No pregnancy safety data 5
• Ditans (lasmiditan): No pregnancy safety data 5
• Opioids and butalbital: Should not be used per current guidelines 5, 2

Preventive Treatment

When to Consider Prevention

Initiate preventive therapy only when:

• Migraine remains severely disabling despite adequate acute treatment
• Patient cannot tolerate acute treatments
• Acute medication overuse is occurring (≥10 days/month for triptans, ≥15 days/month for acetaminophen)

Preventive Medication Options

First-Line: Propranolol

• Propranolol is the preferred preventive agent in pregnancy 2, 3
• Start low (20-40 mg daily) and titrate gradually
• Monitor for fetal growth restriction with chronic use

Second-Line Alternatives:

• Amitriptyline: Can be considered at low doses (10-25 mg at bedtime) 2, 3
• Verapamil: May be used as alternative 2

Medications to AVOID for Prevention:

• Valproate/divalproex: Absolutely contraindicated - major teratogen causing neural tube defects and developmental delays
• Topiramate: Avoid - associated with oral clefts and low birth weight
• ACE inhibitors/ARBs: Contraindicated - renal agenesis and other fetal abnormalities

Non-Pharmacological Approaches

These should be emphasized as first-line for all pregnant patients:

• Maintain regular sleep schedule (7-9 hours nightly)
• Eat regular meals, avoid prolonged fasting
• Stay well-hydrated (8-10 glasses water daily)
• Identify and avoid specific triggers (keep headache diary)
• Consider biofeedback, relaxation training, or cognitive behavioral therapy 6, 7, 3
• Cold compresses to head/neck during attacks

Critical Counseling Points

Preconception Planning

• Discuss migraine management BEFORE pregnancy with all women of childbearing potential 3, 8
• Transition off teratogenic preventives (valproate, topiramate) before conception
• Establish safe acute treatment plan

Risk-Benefit Discussion

• Untreated severe migraine itself carries risks: preterm delivery, preeclampsia, low birth weight 7, 3, 8
• Balance medication risks against risks of uncontrolled migraine
• Document shared decision-making conversations

Medication Overuse Headache

• Monitor for overuse: ≥10 days/month triptan use, ≥15 days/month acetaminophen use 5
• This threshold is LOWER for triptans than for acetaminophen
• Overuse can worsen migraine frequency and severity

Red Flags Requiring Urgent Evaluation

• New or different headache pattern in pregnancy
• Headache with hypertension (consider preeclampsia)
• Headache with focal neurological signs
• Sudden severe "thunderclap" headache
• Progressive or refractory headache 7, 2

Breastfeeding Considerations

Treatment is less restrictive during lactation than pregnancy:

• Acetaminophen remains first-line and is safe
• Sumatriptan is compatible with breastfeeding - minimal infant exposure 4, 3
• NSAIDs (ibuprofen preferred over naproxen) are generally safe
• Most preventives have limited data but propranolol and amitriptyline have better safety profiles 2, 3

Key Clinical Pitfalls

1. Not using adequate doses of acetaminophen before escalating - ensure 1000 mg doses are tried
2. Using NSAIDs after 20 weeks gestation - absolute contraindication
3. Prescribing ergots or newer agents (gepants/ditans) without recognizing pregnancy contraindications
4. Leaving severe migraine untreated - untreated migraine has its own maternal-fetal risks
5. Not counseling about medication overuse thresholds - different for different drug classes

The 2025 ACP guidelines 5 specifically note that in pregnant patients, clinicians must discuss adverse effects of pharmacologic treatments during pregnancy and lactation, emphasizing the importance of individualized risk-benefit assessment for each patient's clinical situation.